Approvals Accorded under PLI Scheme for Domestic Manufacturing of critical Key KSMs/ Drug Intermediates and APIs
Approvals have been accorded to 16 applicants under Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country. The setting up of these 16 plants will lead to total committed investment of Rs. 348.70 crore (US$ 46.39 million) and employment generation of about 3,042 by the companies. The commercial production of these plants is projected to commence from 1st April 2023 onward.